CAV1 and metabolic dysfunction-associated steatotic liver disease: Consistent with our observations, a recent study showed that CAV1 promotes cancer cell survival in the fatty-acid-rich microenvironment of NAFLD [71], suggesting CAV1 also aids the adaptation of non-cancerous cells in such environments.